Free Trial

Clorox (CLX) Stock Forecast & Price Target

$163.33
+1.29 (+0.80%)
(As of 09/20/2024 ET)

Clorox - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Based on 18 Wall Street analysts who have issued ratings for Clorox in the last 12 months, the stock has a consensus rating of "Reduce." Out of the 18 analysts, 6 have given a sell rating, and 12 have given a hold rating for CLX.

Consensus Price Target

$143.50
-12.14% Downside
High Forecast$170.00
Average Forecast$143.50
Low Forecast$120.00

According to the 18 analysts' twelve-month price targets for Clorox, the average price target is $143.50. The highest price target for CLX is $170.00, while the lowest price target for CLX is $120.00. The average price target represents a forecasted downside of -12.14% from the current price of $163.33.

TypeCurrent Forecast
9/23/23 to 9/22/24
1 Month Ago
8/24/23 to 8/23/24
3 Months Ago
6/25/23 to 6/24/24
1 Year Ago
9/23/22 to 9/23/23
Consensus Rating
Reduce
Reduce
Reduce
Reduce
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
1 Buy rating(s)
Hold
12 Hold rating(s)
12 Hold rating(s)
13 Hold rating(s)
7 Hold rating(s)
Sell
6 Sell rating(s)
6 Sell rating(s)
5 Sell rating(s)
6 Sell rating(s)
Consensus Price Target$143.50$141.94$145.33$147.64
Forecasted Upside-12.14% Downside1.10% Upside2.99% Upside-1.37% Downside
Get Clorox Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CLX and its competitors with MarketBeat's FREE daily newsletter.

CLX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CLX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Clorox Stock vs. The Competition

TypeCloroxConsumer Staples CompaniesS&P 500
Consensus Rating Score
1.67
2.45
2.50
Consensus RatingReduceHoldModerate Buy
Predicted Upside-12.14% Downside621.84% Upside7.41% Upside
News Sentiment RatingPositive News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
9/6/2024BNP Paribas
3 of 5 stars
K. Grundy
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong Sell
9/6/2024Citigroup
3 of 5 stars
 Boost TargetNeutral ➝ Neutral$165.00 ➝ $170.00+2.78%
9/6/2024DA Davidson
3 of 5 stars
 Reiterated RatingNeutral ➝ Neutral$153.00 ➝ $153.00-7.55%
8/5/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetUnderweight ➝ Underweight$122.00 ➝ $130.00-8.87%
8/2/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$150.00 ➝ $148.00+2.71%
8/2/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$144.00 ➝ $151.00+4.93%
7/23/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
R. Moskow
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageSell$122.00-8.31%
7/10/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetUnderweight ➝ Underweight$135.00 ➝ $130.00-1.70%
6/4/2024Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
T. Conrad
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
5/1/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$164.00 ➝ $159.00+12.63%
5/1/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetUnderperform ➝ Underperform$145.00 ➝ $142.00+1.58%
3/26/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingEqual Weight ➝ Equal Weight$160.00+5.97%
3/26/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderperform ➝ Hold$145.00-3.67%
3/1/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageSell$140.00-8.68%
12/15/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderperform ➝ Neutral$120.00 ➝ $150.00+5.47%
10/12/2023Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderperform ➝ Market Perform$120.00-1.93%
10/5/2023Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Market Perform
9/22/2023HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageHold$146.00+8.47%
8/3/2023Atlantic Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderweight ➝ Neutral
5/3/2023Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$137.00 ➝ $151.00-9.97%
11/2/2022Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetUnderperform$130.00 ➝ $135.00-7.96%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 08:23 AM ET.

CLX Forecast - Frequently Asked Questions

What is Clorox's forecast for 2024?

According to the research reports of 18 Wall Street equities research analysts, the average twelve-month stock price forecast for Clorox is $143.50, with a high forecast of $170.00 and a low forecast of $120.00.

Should I buy or sell Clorox stock right now?

18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Clorox in the last year. There are currently 6 sell ratings and 12 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "reduce" CLX shares.

Does Clorox's stock price have much downside?

According to analysts, Clorox's stock has a predicted downside of -0.26% based on their 12-month stock forecasts.

Has Clorox been upgraded by Wall Street analysts recently?

Over the previous 90 days, Clorox's stock had 1 upgrade by analysts.

What analysts cover Clorox?

Clorox has been rated by research analysts at Barclays, BNP Paribas, Citigroup, DA Davidson, Deutsche Bank Aktiengesellschaft, JPMorgan Chase & Co., TD Cowen, and Wells Fargo & Company in the past 90 days.

Do Wall Street analysts like Clorox more than its competitors?

Analysts like Clorox less than other "consumer staples" companies. The consensus rating for Clorox is Reduce while the average consensus rating for "consumer staples" companies is Hold. Learn more on how CLX compares to other companies.



This page (NYSE:CLX) was last updated on 9/22/2024 by MarketBeat.com Staff
From Our Partners